- Monday, 09 December 2019
Boulder, CO, USA, December 9, 2019 – An essential patent has been allowed for DMC Biotechnologies’ Dynamic Metabolic Control technology.
Patent number PCT/US2015/035306 with the title ‘Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves’ has been issued by the United Kingdom Intellectual Property Office (UKIPO) to Duke University. DMC has the exclusive license to the technology from Duke.
“The last ten years have shown that bringing biobased products to market takes time. Our Dynamic Metabolic Control technology can accelerate commercialization by making fermentation scale-up more predictable, robust, and efficient. Receiving this patent allowance is another milestone for DMC and is meaningful to our team, our partners, and our investors,” said Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC.